Lumos Diagnostics Holdings Monthly Analysis (March 2026)

Lumos Diagnostics Ho...

ASX:LDX

$ 0,26

$-0,01 (-3,70%)

0,26 $

$-0,01 (-3,70%)

End-of-day quote: 03/27/2026

Lumos Diagnostics Holdings Stock Value

Analysts currently see ASX:LDX at the level of sf_No Opinion.

sf_No Opinion

Lumos Diagnostics Holdings Company Info

EPS Growth 5Y

67,74%

Market Cap

$0,20 B

Long-Term Debt

$0,02 B

Short Interest

0,00%

Quarterly earnings

05/27/2026

Dividend

$0,00

Dividend Yield

0,00%

Founded

2018

Industry

Health Care

Country

United States

ISIN Number

AU0000157091

Website

http://lumosdiagnostics.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$0,28

7.69%

Last Update: 03/28/2026

Analysts: 1

Highest Price Target $0,28

Average Price Target $0,28

Lowest Price Target $0,28

In the last five quarters, Lumos Diagnostics Holdings’s Price Target has risen from $0,06 to $0,06 - a 0,00% increase. One analysts predict that Lumos Diagnostics Holdings’s share price will increase in the coming year, reaching $0,28. This would represent an increase of 7,69%.

Top growth stocks in the health care sector (5Y.)

What does Lumos Diagnostics Holdings do?

Lumos Diagnostics Holdings Limited focuses on providing point-of-care diagnostic solutions that cater to a variety of healthcare needs. The company concentrates on developing and commercializing technologies that enable diagnostic testing, streamlining the clinical diagnostics landscape. With its operations largely based in Australia and the United States, the company specializes in creating diagnostic tests that are essential in emergency and primary medical care settings. Business Segments T...

Business Segments

The company operates principally across one operating segment which is the provision of point-of-care diagnostics goods and services. This segment focuses on delivering diagnostic testing capabilities that are crucial in various healthcare environments.

The company’s operations are geographically separated into two regions: the United States and Australia. In the US, the company has developed a market presence, leveraging the demand for rapid diagnostic testing in various healthcare settings, particularly under circumstances where timely decision-making is paramount. In Australia, the company maintains operations that are aimed at both domestic healthcare providers and export markets, enriching the diagnostic capabilities available to medical institutions in these territories.

Business Strategy

Market penetration remains a crucial aspect of the company’s strategy. The company actively seeks to expand its footprint in existing markets while exploring new markets with unmet diagnostic needs. This approach allows for leveraging current capabilities while forging new opportunities.

Furthermore, the company emphasizes strong partnerships with healthcare providers and scientific institutions. Through strategic alliances, it can capitalize on shared expertise and resources that facilitate co-development of new products, ensuring a more robust response to market demands.

Products and Services

The company specializes in the creation and commercialization of diagnostic tests designed to facilitate medical decision-making. The company’s product range encompasses various point-of-care diagnostic solutions that are vital in areas such as infectious diseases, metabolic disorders, and other health conditions that require quick assessment and treatment.

The company’s flagship products utilize technologies that enable seamless integration into clinical workflows. Key offerings include rapid test kits that can yield results in a matter of minutes. This rapid turnaround supports improved patient management and has the potential to enhance health outcomes, particularly in acute care scenarios.

Moreover, the company’s services extend beyond product provision. The company aims to uphold strong customer relations through comprehensive support services, including training, technical assistance, and ongoing product evaluation. Such services ensure that healthcare providers can effectively implement and utilize the diagnostic tools provided by the company.

Geographical Markets Served

The company operates primarily in two geographical markets: the United States and Australia. In these regions, the company has established a significant presence in the healthcare landscape, providing essential diagnostic services that meet local healthcare demands.

Customers

The company serves a diverse range of customers within the healthcare sector, emphasizing partnerships with healthcare providers, hospitals, and laboratories. The company has established key relationships with major customers who contribute significantly to its revenue streams. As of June 30, 2023, notable customers include entities categorized as large hospitals, healthcare systems, and private labs.

Modes of Sales and Marketing

The company employs a multi-faceted approach to sales and marketing, emphasizing both direct and indirect channels.

Marketing efforts are complemented by participation in industry conferences, workshops, and trade shows where the company showcases its diagnostic innovations to a broader audience, enhancing brand visibility. Digital marketing initiatives also play a role in driving awareness and engagement, particularly with younger healthcare professionals and institutions exploring modern diagnostic solutions.

Additionally, the company uses distributors and partners to expand its reach, ensuring products are accessible across various healthcare settings.

History

Lumos Diagnostics Holdings Limited was incorporated in 2018.

New support ticket

Explore

Lumos Diagnostics Holdings Stock Value

Lumos Diagnostics Holdings Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Lumos Diagnostics Holdings do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Lumos Diagnostics Holdings Stock Value

Lumos Diagnostics Holdings Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Lumos Diagnostics Holdings do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.